Inhaled steroids for acute asthma following emergency department discharge

Cochrane Database of Systematic Reviews

Volumn 2018, Issue 8, 2012, Pages

  Edmonds, Marcia L ^a   Milan, Stephen J ^b   Brenner, Barry E ^c   Camargo Jr, Carlos A ^d   Rowe, Brian H ^e,f  

^a WESTERN UNIVERSITY   (Canada)

^b LANCASTER UNIVERSITY   (United Kingdom)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e UNIVERSITY OF ALBERTA   (Canada)

^f UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; ANTIINFLAMMATORY AGENT; GLUCOCORTICOID; STEROID;

ACUTE DISEASE; ASTHMA; EMERGENCY HEALTH SERVICE; HOSPITAL DISCHARGE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; META ANALYSIS; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

ACUTE DISEASE; ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; EMERGENCY SERVICE, HOSPITAL; GLUCOCORTICOIDS; HUMANS; PATIENT DISCHARGE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STEROIDS;

MLCS; MLOWN;

EID: 84874183419     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD002316.pub2     Document Type: Article

References (130)

1. Brenner BE, Chavda KK, Camargo CA Jr. Randomized trial of inhaled flunisolide versus placebo among asthmatic patients discharged from the emergency department. Annals of Emergency Medicine 2000;36:417-26. x-wiley/crsRef/2704454
2. Camargo C Jr, on behalf of the MARC investigators. Randomized trial of medium-dose fluticasone vs. placebo after an emergency department visit for acute asthma. AAAAI 56th Annual Meeting 2000. x-wiley/crsRef/2704456
3. Di Franco A, Bacci E, Laura Bartoli M, Cianchetti S, Dente FL, Taccola M, et al. Inhaled fluticasone propionate is effective as well as oral prednisone in reducing sputum eosinophilia during exacerbations of asthma which do not require hospitalization. Pulmonary Pharmacology & Therapeutics 2006; Vol. 19, issue 5:353-60. x-wiley/crsRef/2704458
4. Fitzgerald JM, Shragge DL, Haddon JMF, Jennings B, Lee J, Bai A, et al. A randomized, controlled trial of high does, inhaled budesonide versus oral prednisone in patients discharged from the emergency department following an acute asthma exacerbation. Canadian Respiratory Journal 2000;7(1):61-7. x-wiley/crsRef/2704460
5. Grunfeld AF, Bai A, Shragge DL, Haddon JMF, Lee J, Jennings B, et al. High dose inhaled budesonide versus prednisone in patients with acute asthma discharged from the emergency department. Clinical and Investigative Medicine 1997;20(4):S15. x-wiley/crsRef/2704461
6. Francis P, Geelhoed G, Harris MA, Morton J, Efthimiou J, Barnacle H. Effect of nebulised fluticasone propionate 1 mg twice daily compared with oral prednisolone in pre-school children aged 48 months or less with an acute exacerbation of asthma. European Respiratory Journal 1997;10 Suppl 25:275s. x-wiley/crsRef/2704463
7. Levy ML, Stevenson C, Maslen T. Comparison of short courses of oral prenisolone and fluticasone proprionate in the treatment of adults with acute exacerbations of asthma in primary care. Thorax 1996;51:1087-92. x-wiley/crsRef/2704465
8. Bingham A, Manjra AL, Lee BW, Panov M, Putnik U, Barnacle H, et al. A comparison of the effect of nebulised fluticasone propionate 1 mg twice daily with oral prednisolone in children aged 4-16 years with an acute exacerbation of asthma. American Journal of Respiratory and Critical Care Medicine 1998;157(3):A404. x-wiley/crsRef/2704467
9. Manjra AI, Lee BW, Panov M, Putnik U, Efthimiou J, Barnacle H. Effect of nebulised fluticasone propionate 1 mg twice daily compared with oral prednisolone in children aged 4-16 years with an acute exacerbation of asthma. European Respiratory Journal 1997; Vol. 10 Suppl 25:275S. x-wiley/crsRef/2704468
10. Manjra AI, Price J, Lenney W, Hughes S, Barnacle H. Efficacy of nebulized fluticasone propionate compared with oral prednisolone in children with an acute exacerbation of asthma. Respiratory Medicine 2000;94:1206-14. x-wiley/crsRef/2704469
11. Nakanishi AK, Klasner AK, Rubin BK. A randomized controlled trial of inhaled flunisolide in the management of acute asthma in children. Chest 2003; Vol. 124, issue 3:790-4. x-wiley/crsRef/2704471
12. Nana A, Youngchaiyud P, Charoenratanakul S, Boe J, Löfdahl C-G, Selroos O, et al. High-dose inhaled budesonide may substitute for oral therapy after and acute asthma attack. Journal of Asthma 1998;35(8):647-55. x-wiley/crsRef/2704473
13. Rowe BH, Bota GW, Fabris L, Therrien SA, Milner RA, Jacono J. Inhaled budesonide in addition to oral corticosteroids to prevent asthma relapse following discharge from the emergency department. A randomized clinical trial. JAMA 1999;281(22):2119-26. x-wiley/crsRef/2704475
14. Verona E, Ahel V, Williams L, Medley HV. A multicentre, randomized, double-blind, double-dummy, parallel group study comparing efficacy and safety of fluticasone propionate 500ug BID delivered by metered dose inhaler and spacer device with oral soluble prednisolone. American Journal of Respiratory and Critical Care Medicine 1998;157(3):A711. x-wiley/crsRef/2704477
15. Volovitz B, Bentur L, Finkelstein Y, Mansour Y, Shalitin S, Nussinovitch M, et al. Effectiveness and safety of inhaled corticosteroids in controlling acute asthma attacks in children who were treated in the emergency department: a controlled comparative study with oral prednisolone. Journal of Allergy and Clinical Immunology 1998;102:605-9. x-wiley/crsRef/2704479
16. Volovitz B, Bentur L, Finkelstein Y, Nussinovitch M, Mansour Y, Shalitin S, et al. Effectiveness and safety of inhaled budesonide in controlling acute asthma attacks in children - a controlled study compared to oral prednisolone in the emergency department, and evaluation of efficacy in 150 outpatient children. Journal of Allergy and Clinical Immunology 1998;S10:Abstract 43. x-wiley/crsRef/2704480
17. Agarwal SK, Gupta S. Aerosolized fluticasone propionate therapy in acute moderate exacerbations of asthma. European Respiratory Society Annual Congress 2002:P397. x-wiley/crsRef/2704482
18. Agarwal SK. Utility of aerosolized budesonide therapy in acute moderate exacerbations of asthma. European Respiratory Society Annual Congress 2003; Vol. 22:P1836. x-wiley/crsRef/2704484
19. Agarwal K. Aerosolized budesonide therapy in acute moderate exacerbations of Indian asthmatics. European Respiratory Journal 2004; Vol. 24:343s. x-wiley/crsRef/2704486
20. Agarwal SK. Aerosolized budesonide therapy in acute moderate exacerbations of asthma. Chest 2004; Vol. 126:815S. x-wiley/crsRef/2704488
21. Agarwal SK, Singh D, Singh V. Utility of aerosolized fluticasone therapy in the early management of acute moderate exacerbations of asthma in the emergency room. Respirology 2005; Vol. 10:A115. x-wiley/crsRef/2704490
22. Agarwal SK, Arshad N. Aerosolized fluticasone therapy in acute moderate exacerbations of asthma. Chest 2008; Vol. 134:44001s. x-wiley/crsRef/2704492
23. Agarwal SK, Arshad N. Utility of high dose inhaled fluticasone therapy for the early management of acute exacerbations of asthma. European Respiratory Society Annual Congress, Vienna 2009:E4352. x-wiley/crsRef/2704494
24. Agarwal SK, Sharma S. Effect of fluticasone/formoterol pressurized metered-dose inhaler (pMDI) in early management of acute exacerbations of asthma. American Journal of Respiratory and Critical Care Medicine 2010; Vol. 181:A5659. x-wiley/crsRef/2704496
25. Agarwal SK, Sharma S. Utility of inhaled corticosteroids (fluticasone/formoterol) by pressurized metered-dose inhaler for the early management of acute exacerbations of asthma. European Respiratory Society Annual Congress 2010:E5476. x-wiley/crsRef/2704498
26. Allen DJ, Bright-Thomas RJ, McDonnell BM, Pankhania A, Langley SJ, Rossetti A, et al. A single centre open study into the safety of pulvinal? A new dry powder beclomethasone dipropionate (BDP) inhaler in the treatment of mild to severe asthmatics. American Thoracic Society 99th International Conference 2003:C105 Poster D67. x-wiley/crsRef/2704500
27. Ancheta VA, Jiao AGQ, Erguiza GSD, Arellano MA, Dizon CC, Catacutan MS. Comparison of inhaled fluticasone propionate versus intravenous hydrocortisone in the treatment of severe asthma exacerbation in children aged 6-18 years. Chest 2008; Vol. 134:24002s. x-wiley/crsRef/2704502
28. Anonymous. Withdrawal of corticosteroid therapy after acute asthma attacks. CMAJ 1995;153(10):1471. x-wiley/crsRef/2704504
29. Balanag VM, Yunus F, Yang PC, Jorup C. Budesonide/formeterol in a single inhaler is as effective and well tolerated as salbutamol in relieving acute asthma in adults and adolescents. European Respiratory Journal 2003; Vol. 22:P2836. x-wiley/crsRef/2704506
30. Bateman ED, Fairall L, Lombardi DM, English R. Budenoside/formoterol and formoterol provide similar rapid relief in patients with acute asthma showing refractoriness to salbutamol. Respiratory Research 2006;7:13. x-wiley/crsRef/2704508
31. Bautista MS, Balderas J. The efficacy of combined inhaled steroids and beta-2 agonist in the treatment of acute asthma in children 6-18 years of age versus inhaled beta-2 agonist alone. European Respiratory Journal 1994; Vol. 7 Suppl 18:93s. x-wiley/crsRef/2704510
32. Becker A, Chung K, Lee J. Randomised, controlled, multi-centre study to compare double-dose versus maintenance dose of inhaled corticosteroids (ICS) during asthma exacerbations. American Journal of Respiratory and Critical Care Medicine 2000;161 Suppl(3):A187. x-wiley/crsRef/2704512
33. Belda J, Margarit G, Martinez C, Bellido-Casado J, Casan P, Torrejon M, et al. Anti-inflammatory effects of high-dose inhaled fluticasone versus oral prednisone in asthma exacerbations. European Respiratory Journal 2007;30(6):1143-9. x-wiley/crsRef/2704514
34. Bilancia R, Caputo F, Margiotta D, Sebastio G, Balacco D, Mastrandrea L. Oral metil prednisolone vs fluticasone propionate in the treatment of patients hospitalized for middle exacerbation of asthma. ALA/ATS Abstracts. 1998; Vol. A403. x-wiley/crsRef/2704516
35. Blandon MV, Rosas MA, Del Rio BE, Sienra JJ. Comparison of effectiveness between nebulized budesonide plus albuterol versus albuterol alone in children with moderate acute asthma. Journal of Allergy and Clinical Immunology 2004;113 Suppl(2):S118. x-wiley/crsRef/2704518
36. Britton MG, Bone MF, Boyd G, Catterall JR, Ward MJ, Richards K. Comparison of a lower fixed dose of inhaled fluticasone propionate (FP) with a high dose step-down regimen of FP in the prevention of re-exacerbations after an acute severe attack of asthma requiring oral corticosteroid therapy. Thorax 1997;52(Suppl 6):A1. x-wiley/crsRef/2704520
37. Chhabra SK. A comparison of inhaled salbutamol with a combination of salbutamol and beclomethasone dipropionate in moderately severe asthma. Indian Journal of Chest Diseases and Allied Science 1994; Vol. 36, issue 3:119-24. x-wiley/crsRef/2704522
38. Cox F, Goodwin B, Pepsin PJ, Rogenes P, Anschuetz G, Pleskow W, et al. Superior impact of inhaled fluticasone propionate 500 μg/day versus triamcinolone acetonide 800 μg/day or placebo on asthma-specific quality of life in asthmatics. American Journal of Respiratory and Critical Care Medicine 1996;153(4 Part 2):A340. x-wiley/crsRef/2704524
39. Crain EF. Effect of inhaled formoterol and budesonide on exacerbations of asthma; N Engl J Med 336:1405-1411, 1997. Emergency and Office Pediatrics 1998;11(2):76-7. x-wiley/crsRef/2704526
40. Cueva JV, Sucilla H, Gorocica D, Cicero R, Durazo F. Beclomethasone dipropionate - adrenal function and acute asthma. Postgraduate Medical Journal 1975;51 Suppl 4:87. x-wiley/crsRef/2704528
41. Decimo F, Maiello N, Miraglia Del Giudice M, Amelio R, Capristo C, Capristo AF. High-dose inhaled flunisolide versus budesonide in the treatment of acute asthma exacerbations in preschool-age children. International Journal of Immunopathology & Pharmacology 2009;22:363-70. x-wiley/crsRef/2704530
42. Drblik S, Lapierre G, Thivierge R, Turgeon J, Gaudreault P, McManus B, et al. Comparative efficacy of terbutaline sulphate delivered by Turbuhaler dry powder inhaler or pressurized metered dose inhaler+nebuhaler spacer in children during an acute asthmatic episode (unpublished). Astra Pharma. x-wiley/crsRef/2704532
43. Ediger D, Coskun F, Kunt Uzaslan E, Gurdal Yuksel E, Karadag M, Ege E, et al. Clinical effectiveness of nebulised budesonide in the treatment of acute asthma attacks. Tuberkuloz ve Toraks 2006;54(2):128-36. x-wiley/crsRef/2704534
44. Estrada-Reyes E, Del Rio-Navarro BE, Rosas-Vargas MA, Nava-Ocampo AA. Co-administration of salbutamol and fluticasone for emergency treatment of children with moderate acute asthma. Pediatric Allergy & Immunology 2005;16(7):609-14. x-wiley/crsRef/2704536
45. Frye CB. Corticosteroid of choice in the treatment of acute asthma. Drug Intellence & Clinical Pharmacy 1988;22:407. x-wiley/crsRef/2704538
46. Gross G, Wolfe JD, Noonan MJ, Pinnas J, Bollansky H, Nathan RA, et al. Fluticasone propionate 500 mcg/day improves asthma more than triamcinolone acetonide 800mcg/day. American Journal of Respiratory and Critical Care Medicine 1996;153(4 Part 2):A340. x-wiley/crsRef/2704540
47. Higenbottam TW, Britton J, Lawrence D, Connolly CK, Harrison NK, Eastham HM, et al. Comparison of nebulised budesonide and prednisolone in severe asthma exacerbation in adults. Biodrugs 2000; Vol. 14, issue 4:247-54. [EMBASE 2000392806]x-wiley/crsRef/2704542
48. Jerez FR, Brufal M, Bellido J, Margarit G, Torrejon M, Belda J, et al. Inhaled corticosteroids in the treatment of acute asthma. European Respiratory Society Annual Congress 2002:P1917. x-wiley/crsRef/2704544
49. Joubert JR, Burger G, Shephard E. Inhalation therapy during acute asthma. The role of a combined steroid and beta-stimulant preparation. South African Medical Journal 1985;68:381-4. x-wiley/crsRef/2704546
50. Khoo SM, Lim TK. Effects of inhaled versus systemic corticosteroids on exhaled nitric oxide in severe acute asthma. Respiratory Medicine 2009;103.(4.):614-20. x-wiley/crsRef/2704548
51. La Rosa M, Ranno C, Mandarà G, Barbato A, Biraghi M. Double-blind study of inhaled salbutamol versus salbutamol plus high-dose flunisolide in exacerbation of bronchial asthma: a pilot study. Pediatric Asthma Allergy and Immunology 1997;11(1):23-30. x-wiley/crsRef/2704550
52. Latysheva TV, Ilina NI. Experience in using Celeston (betamethasone) in emergency states in allergology [Russian]. Anesteziologiia i Reanimatologiia 1996;3:48-50. x-wiley/crsRef/2704552
53. Lee-Wong M, Dayrit FM, Kohli AR, Acquah S, Mayo PH. Comparison of high-dose inhaled flunisolide to systemic corticosteroids in severe adult asthma. Chest 2002;122(4):1208-13. x-wiley/crsRef/2704554
54. Leuppi JD, Sownie SR, Salome CM, Jenkins CR, Woolcock AJ. A single high dose of inhaled corticosteroids: a possible treatment of asthma exacerbations. Swiss Medical Weekly 2002;132(1-2):7-11. x-wiley/crsRef/2704556
55. Lim TK. Comparison of inhaled fluticasone propionate and oral prednisolone in the treatment of acute severe asthma. American Journal of Respiratory and Critical Care Medicine 1996;153(4 Part 2):A340. x-wiley/crsRef/2704558
56. Macias CG, Felner EI, Gan V. Inhaled corticosteroids may be superior to systemic corticosteroids in children with moderate-to-severe acute asthma. Pediatric Asthma Allergy and Immunology 2003;16(3):121-8. x-wiley/crsRef/2704560
57. Mahakalkar SM, Tibdewal S, Khobragade BP. Cardio-pulmonary effects of various anti-asthmatic agents in patients of acute bronchial asthma. Indian Practitioner 2002; Vol. 55:79-85. x-wiley/crsRef/2704562
58. Mannan SE, Yousef E, McGeasdy SJ, duPont AI. Early intervention with high dose inhaled corticosteroids for control of acute asthma exacerbations and improved outcomes a randomized controlled trial. Journal of Allergy and Clinical Immunology 2008; Vol. 1121:S219. x-wiley/crsRef/2704564
59. McEvoy JDS, Edwards RL. Beclomethasone dipropionate in acute asthma. Australian & New Zealand Journal of Medicine 1977; Vol. 7:665. [0004-8291]x-wiley/crsRef/2704566
60. Mendes ES, Horvath G, Campos M, Wanner A. Rapid corticosteroid effect on beta2-adrenergic airway and airway vascular reactivity in patients with mild asthma. Journal of Allergy and Clinical Immunology 2008; Vol. 121, issue 3:700-4. x-wiley/crsRef/2704568
61. Milani GK, Rosario Filho NA, Riedi CA, Figueiredo BC. Nebulized budesonide to treat acute asthma in children [Budesonida inalatoria em criancas com asma aguda]. Jornal de Pediatria 2004;80(2):106-12. x-wiley/crsRef/2704570
62. Mitchell CA, Alpers JH, Morton SM, Baggoley CJ, Croker WD, Walsh AJ, et al. Comparison of nebulized budesonide with oral prednisolone in the treatment of severe acute asthma. European Respiratory Journal 1995;8 Suppl 19:490S. x-wiley/crsRef/2704572
63. Morice AH, Morris D, Lawson-Matthew P. A comparison of nebulized budesonide with oral prednisolone in the treatment of exacerbations of obstructive pulmonary disease. Clinical Pharmacology and Therapeutics 1996;60(6):675-8. x-wiley/crsRef/2704574
64. Nana A, Youngchaiyud P, Maranetra N, Boe J, Lofdahl CG, Selroos O, Stahl E. B2-agonists administered by a dry powder inhaler can be used in acute asthma. Respiratory Medicine 1998;92:167-72. x-wiley/crsRef/2704576
65. Nuhoglu Y, Bahceciler NN, Barlan IB, Basaran MM. The effectiveness of high-dose inhaled budesonide therapy in the treatment of acute asthma exacerbations in children. Annals of Allergy Asthma and Immunology 2001;86:318-22. x-wiley/crsRef/2704578
66. O'Byrne PM. Acute asthma intervention: insights from the STAY study. Journal of Allergy & Clinical Immunology 2007; Vol. 119:1332-6. x-wiley/crsRef/2704580
67. O' Byrne P, Pedersen S, Lamm C-J, Tan W, Busse W. Severe exacerbations, decline in lung function and inhaled budesonide in asthma. European Respiratory Journal 2007;30 Suppl 51:P3634. x-wiley/crsRef/2704582
68. Oborne J, Hubbard RB, Tattersfield AE, Harrison TW. Can acute exacerbations of asthma be prevented with a four-fold increase in inhaled corticosteroid dose?. American Thoracic Society International Conference, May 15-20, 2009, San Diego. 2009. A2794. 2009. x-wiley/crsRef/2704584
69. *Olaivar EA, Tuazon AO, Martirez T, Gaerlan EB. Nebulized budesonide in the management of acute asthma. American Journal of Respiratory and Critical Care Medicine 1999;159(3):A142. x-wiley/crsRef/2704586
70. Pauwels RA, Pedersen S, Busse WW, Tan WC, Chen YZ, Ohlsson SV, et al. Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. Lancet 2003; Vol. 361, issue 9363:1071-6. [0140-6736]x-wiley/crsRef/2704588
71. Pierson WE, Bierman CW, Kelley VC. A double blind trial of corticosteroid treatment in status asthmaticus. Pediatrics 1974;54(3):282-8. x-wiley/crsRef/2704590
72. Postma DS, Ind PW, Magnussen H, van den Berge M. A double-blind, randomized, controlled study comparing the efficacy and safety of inhaled ciclesonide with oral prednisolone in patients with an asthma exacerbation. Proceedings of the American Thoracic Society 2006:A74. x-wiley/crsRef/2704592
73. Postma S, Arshad H, Hamelmann H, van den B. Efficacy of inhaled ciclesonide compared with oral prednisolone in the treatment of asthma exacerbations. European Respiratory Journal 2006; Vol. 28:P1235. x-wiley/crsRef/2704593
74. Rabe KF, Atienza T, Magyar P, Larsson P, Jorup C, Lalloo UG. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. Lancet 2006368(9537):744-53. x-wiley/crsRef/2704595
75. Rahman M, Hossain A, Hossain DA. Comparative study of inhaled corticosteroid with systemic corticosteroids in the management of acute asthma at emergency department. Respirology 2007; Vol. 12 Suppl 4:A146. x-wiley/crsRef/2704597
76. Rahmam MM, Hossain DA, Hossain A. Comparative study of inhaled corticosteroid with systemic corticosteroid in the management of acute asthma at emergency department. Respirology 2008; Vol. 13 Suppl 5:A131. x-wiley/crsRef/2704599
77. Razi CH, Turktas I, Bakirtas A. Comparison of single 2000-microg dose treatment vs. sequential repeated-dose 500-microg treatments with nebulized budesonide in acute asthma exacerbations. Annals of Allergy, Asthma and Immunology 2008; Vol. 100, issue 4:370-6. x-wiley/crsRef/2704601
78. Rice McDonald G, Bowler S, Staines G, Mitchell C. Doubling inhaled corticosteroids (ICS) is ineffective in mild to moderately sever attacks of asthma in adults. Respirology 2002; Vol. 7:A24 P40. x-wiley/crsRef/2704603
79. Salmeron S, Guerin J-C, Godard P, Renon D, Henry-Amar M, Duroux P, et al. High doses of inhaled corticosteroids in unstable chronic asthma. American Review of Respiratory Diseases 1989;140:167-71. x-wiley/crsRef/2704605
80. NCT00294398. Inhaled corticosteroids after a pediatric emergency visit for asthma. clinicaltrials.gov/ct2/show/NCT00294398 (accessed 18 September 2012). x-wiley/crsRef/2704607
81. Sampayo EM, Chew A, Mechak J, Skilton FJ, Mazer M, Scarfone R, et al. Initiation of inhaled corticosteroids after a pediatric emergency visit for asthma: a randomized clinical trial. Pediatric Emergency Care 2010;26(9):699. x-wiley/crsRef/2704608
82. Schuh S, Dick PT, Stephens D, Hartley M, Khaikin S, Rodrigues L, Coates AL. High-dose inhaled fluticasone does not replace oral prednisolone in children with mild to moderate acute asthma. Pediatrics 2006;118(2):644-50. x-wiley/crsRef/2704610
83. Sekerel BE, Sackesen C, Tuncer A, Adalioglu G. The effect of nebulized budesonide treatment in children with mild to moderate exacerbations of asthma. Acta Paediatrica 2005;94(10):1372-7. x-wiley/crsRef/2704612
84. Sharma S, Godatwar P, Kulkarni LR. Salbutamol and/or beclomethasone diproprionate in asthma. Indian Journal of Pediatrics 2003;20(2):129-32. x-wiley/crsRef/2704614
85. Sheikh S, Howell L, Eid N. Comparison of inhaled fluticasone proprionate 880 μg/day with flunisolide 1500 μg/day in severe persistent asthma. European Respiratory Journal 1998;12 Suppl 29:81s, P634. x-wiley/crsRef/2704616
86. NCT00189436. Effect of nebulized budesonide and oral corticosteroids on wheezing episode relapse in children (BudER). http://clinicaltrials.gov/show/NCT00189436 (accessed 18 September 2012). x-wiley/crsRef/2704618
87. Skoner D, Koehrsen J, Patel A, Barth H, Gentile D. Comparison of nebulized budesonide versus oral steroids for the treatment of outpatient asthma in children aged 1 to 8 years. Journal of Allergy and Clinical Immunology 2009;S158:604. x-wiley/crsRef/2704619
88. Skorpinski EW, Yousel E, McGeady SJ. Early intervention with high-dose inhaled corticosteroids for control of acute asthma exacerbations and improved outcomes a randomized controlled trial. Journal of Allergy and Clinical Immunology 2006; Vol. 117 Suppl 1, issue 2:S93. x-wiley/crsRef/2704621
89. Starobin D, Bolotinsky L, Or J, Fink G, Shtoeger Z. Efficacy of nebulized fluticasone propionate in adult patients admitted to the emergency department due to bronchial asthma attack. Israel Medical Association Journal 2008;10(8-9):568-71. x-wiley/crsRef/2704623
90. Svedmyr J, Nyberg E, Åsbrink-Nilsson E, Hedlin G. Intermittent treatment with inhaled steroids for deterioration of asthma due to upper respiratory tract infections. Acta Pædiatrica 1995;84:884-8. x-wiley/crsRef/2704625
91. Volovitz B, Nussinovitch M, Finkelstein Y, Harel L, Varsano I. Effectiveness of inhaled corticosteroids in controlling acute asthma exacerbations in children at home. Clinical Pediatrics 2001;40(2):79-86. x-wiley/crsRef/2704627
92. Wendel PJ, Ramin SM, Barnett-Hamm C, Rowe TF, Cunningham FG. Asthma treatment in pregnancy: a randomized controlled study. American Journal of Obstetrics and Gynecology 1996;175(1):150-4. x-wiley/crsRef/2704629
93. Wilson NM, Silverman M. Treatment of acute, episodic asthma in preschool children using intermittent high dose inhaled steroids at home. Archives of Disease in Childhood 1990;65:407-10. x-wiley/crsRef/2704631
94. Winter JH, Dhillon DP, Winter JE, Feeney Y, Allen D, Maslen T. Effect of the early substitution of nebulised fluticasone propionate 2 mg bd for oral prednisolone 50 mg od in adults during the early recovery period of an acute exacerbation. European Respiratory Journal 1997;10 Suppl 25:174S. x-wiley/crsRef/2704633
95. Yang S, Feng E, Suo Y. Inhaled budesonide for severe asthma at high altitude. Chinese Journal of Tuberculosis & Respiratory Diseases 2000;23(10):613-6. x-wiley/crsRef/2704635
96. Yashina LO, Gorovenko NG, Gogunska IV. Efficacy of high doses of inhaled corticosteroids in treatment of asthma exacerbation. Ukrainian Journal of Pulmonology 2001;3:21-5. x-wiley/crsRef/2704637
97. Yi TY, Li JM, Li QL. Budesonide in combination with salbutamol in the treatment of 61 cases of childhood bronchial asthma during acute episodes. Herald of Medicine 2003; Vol. 22, issue 8:540-1. x-wiley/crsRef/2704639
98. Zhou ZY, Wang ZF, Chen J, Chen Y, Wang CZ. Treatment of severe asthma with large dosage of inhaled beclometasone. Acta Academiae Medicine Militaris Tertiae 2000; Vol. 6:591-3. x-wiley/crsRef/2704641
99. Acun C, Tomac N, Sogut A, Demirel F, Yuksel B. A comparison of inhaled budesonide and oral prednisolone for children with acute asthma. European Respiratory Journal 2003; Vol. 22:P887. x-wiley/crsRef/2704643
100. Ambrosio MI, Ramiro A, Dyseng J. A comparative study on terbutaline + budesonide versus terbutaline alone given through nebulization in the treatment of acute exacerbations of asthma in adults. Philippine Scientific Journal 1997; Vol. 6:42-7. x-wiley/crsRef/2704645
101. Demirca BP, Cagan H, Kiykim A, Arig U, Arpa M, Tulunay A, et al. Nebulized fluticasone propionate, a viable alternative to systemic route in the management of childhood moderate asthma attack: A double-blind, double-dummy study. Respiratory Medicine 2015;109(9):1120-5. x-wiley/crsRef/9032408
102. Sampayo EM, Mazer-Amirshahi M, Camp EA, Zorc JJ. Initiation of an inhaled corticosteroid during a pediatric emergency visit for asthma: a randomized clinical trial. Annals of Emergency Medicine 2017;70(3):331-37. x-wiley/crsRef/9032410
103. Andrews AL, Teufel RJ, Basco WT, Simpson KN. A cost-effectiveness analysis of inhaled corticosteroid delivery for children with asthma in the emergency department. Journal of Pediatrics 2012 Jun 18;[Epub ahead of print]:[Epub ahead of print]. [DOI: 10.1016/j.jpeds.2012.05.015]
104. Ausejo Segura M, Saenz A, Ba'Pham, Kellner JD, Johnson DW, Moher D, et al. The effectiveness of glucocorticoids in treating croup: meta-analysis. BMJ 1999;319:595.
105. Barnes PJ. Inhaled glucocorticoids for asthma. New England Journal of Medicine 1995;332(13):868-75.
106. Boulet L-P, Becker A, Bérubé D, Beveridge RC, Ernst P, on behalf of the Canadian Asthma Consensus Group. Management of patients with asthma in the emergency department and in the hospital. CMAJ 1998;161(11 Suppl):S53-9.
107. British Thoracic Society/Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. A national clinical guideline. May 2008. Revised Jan 2012. www.sign.ac.uk/guidelines/fulltext/101/index.html (accessed 18 September 2012).
108. Edmonds ML, Camargo CA Jr, Pollack CV, Rowe BH. Early use of inhaled corticosteroids in the emergency department treatment of acute asthma. Cochrane Database of Systematic Reviews 2012, Issue 12. [DOI: 10.1002/14651858.CD002308]
109. Emond SD, Camargo CA, Jr, Nowak RM. 1997 National Asthma Education and Prevention Program guidelines: a practical summary for emergency physicians. Annals of Emergency Medicine 1998;31(5):579-89.
110. Expert Panel Report 3 (EPR-3). Guidelines for the Diagnosis and Management of Asthma-Summary Report. Journal of Allergy and Clinical Immunology 2007;120:S94-138.
111. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. December 2011. www.ginasthma.org/guidelines-gina-report-global-strategy-for-asthma.html (accessed 18 September 2012).
112. Green RH, Brightling CE, McKenna S, Hargadon B, Parker D, Bradding P, et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002;360:715-21.
113. Griswold SK, Nordstrom CR, Clark S, Gaeta TJ, Price ML, Camargo CA Jr. Asthma exacerbations in North American adults: Who are the "frequent fliers" in the emergency department?. Chest 2005;127:1579-1586.
114. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org 2011.
115. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 1996;17:1-12.
116. Mannino DM, Homa DM, Pertowski GA, Ashizawa A, Nixon LL, Johnson CA, et al. Surveillance for asthma - United States 1960-1995. Morbidity and Mortality Weekly Report. CDC Surveillance Summaries 1998;47(1):1-28.
117. National Heart Blood and Lung Institute. Expert panel report II: guidelines for the diagnosis and management of asthma. http://www.nhlbi.nih.gov/guidelines/archives/epr-2/index.htm (accessed 18 September 2012).
118. Pauwels RA, Lofdahl CG, Postma DS, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med 1997;337:1405-1411.
119. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
120. Rodrigo G, Rodrigo C. Inhaled flunisolide for acute severe asthma. American Journal of Respiratory and Critical Care Medicine 1998;157:698-703.
121. Rodrigo G, Rodrigo C. Corticosteroids in the emergency department therapy of acute adult asthma: an evidence-based evaluation. Chest 1999;116(2):285-95.
122. Rowe BH, Bota GW, Pollack CV, Camargo CA Jr. Management of asthma among adults presenting to Canadian versus US emergency departments. Annals of Emergency Medicine 1998;32:S1-2.
123. Rowe BH, Spooner CH, Ducharme FM, Bretzlaff JA, Bota GW. Corticosteroids for preventing relapse following acute exacerbations of asthma. Cochrane Database of Systematic Reviews 2003, Issue 1. [DOI: 10.1002/14651858.CD000195.pub2]
124. Rowe BH, Spooner C, Ducharme F, Bretzlaff J, Bota G. Early emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Database of Systematic Reviews 2008, Issue 4. [DOI: 10.1002/14651858.CD002178]
125. Rowe BH, Spooner C, Ducharme F, Bretzlaff J, Bota G. Corticosteroids for preventing relapse following acute exacerbations of asthma. Cochrane Database of Systematic Reviews 2008, Issue 4. [DOI: 10.1002/14651858.CD000195.pub2]
126. Rowe BH, Villa-Roel C, Sivilotti ML, Lang E, Borgundvaag B, Worster A, et al. Relapse after emergency department discharge for acute asthma. Academic Emergency Medicine 2008;15(8):709-17.
127. Rowe BH, Villa-Roel C, Abu-Laban RB, Stenstrom R, Mackey D, Stiell IG, et al. Admissions to Canadian hospitals for acute asthma: a prospective, multicentre study. Canadian Respiratory Journal 2010;17:25-30.
128. Tiffany BR, Berk WA, Todd IK, White SR. Magnesium bolus or infusion fails to improve expiratory flow in acute asthma exacerbations. Chest 1993;104(3):831-4.
129. Verbeek PR, Gerts WH. Nontapering vs tapering prednisone in acute exacerbations of asthma: a pilot study. Journal of Emergency Medicine 1995;13:15-9.
130. Edmonds M, Brenner BE, Camargo CA Jr, Rowe BH. Inhaled steroids for acute asthma following emergency department discharge. Cochrane Database of Systematic Reviews 2000, Issue 3. [DOI: 10.1002/14651858.CD002316]